These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 22888398)

  • 21. Role of antioxidants and a nutrient rich diet in Alzheimer's disease.
    Veurink G; Perry G; Singh SK
    Open Biol; 2020 Jun; 10(6):200084. PubMed ID: 32543351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
    Saeedi M; Rashidy-Pour A
    Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondria as a therapeutic target in Alzheimer's disease and diabetes.
    Moreira PI; Cardoso SM; Pereira CM; Santos MS; Oliveira CR
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):492-511. PubMed ID: 19702564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.
    Reddy PH; Tripathi R; Troung Q; Tirumala K; Reddy TP; Anekonda V; Shirendeb UP; Calkins MJ; Reddy AP; Mao P; Manczak M
    Biochim Biophys Acta; 2012 May; 1822(5):639-49. PubMed ID: 22037588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant treatment in Alzheimer's disease: current state.
    Gilgun-Sherki Y; Melamed E; Offen D
    J Mol Neurosci; 2003; 21(1):1-11. PubMed ID: 14500988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
    Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain.
    Raukas M; Rebane R; Mahlapuu R; Jefremov V; Zilmer K; Karelson E; Bogdanovic N; Zilmer M
    Free Radic Res; 2012 Dec; 46(12):1490-5. PubMed ID: 22962855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress in diabetes and Alzheimer's disease.
    Reddy VP; Zhu X; Perry G; Smith MA
    J Alzheimers Dis; 2009; 16(4):763-74. PubMed ID: 19387111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements.
    Tadokoro K; Ohta Y; Inufusa H; Loon AFN; Abe K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?
    Persson T; Popescu BO; Cedazo-Minguez A
    Oxid Med Cell Longev; 2014; 2014():427318. PubMed ID: 24669288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.
    Stefanova NA; Muraleva NA; Maksimova KY; Rudnitskaya EA; Kiseleva E; Telegina DV; Kolosova NG
    Aging (Albany NY); 2016 Oct; 8(11):2713-2733. PubMed ID: 27750209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents.
    Darvesh AS; Carroll RT; Bishayee A; Geldenhuys WJ; Van der Schyf CJ
    Expert Rev Neurother; 2010 May; 10(5):729-45. PubMed ID: 20420493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant approaches for the treatment of Alzheimer's disease.
    Lee HP; Zhu X; Casadesus G; Castellani RJ; Nunomura A; Smith MA; Lee HG; Perry G
    Expert Rev Neurother; 2010 Jul; 10(7):1201-8. PubMed ID: 20586698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?
    Moreira PI; Smith MA; Zhu X; Honda K; Lee HG; Aliev G; Perry G
    Drug News Perspect; 2005; 18(1):13-9. PubMed ID: 15753972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.
    Singh RK
    Curr Neuropharmacol; 2020; 18(9):868-882. PubMed ID: 31989900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer's Disease.
    Kwon HJ; Cha MY; Kim D; Kim DK; Soh M; Shin K; Hyeon T; Mook-Jung I
    ACS Nano; 2016 Feb; 10(2):2860-70. PubMed ID: 26844592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.
    Resende R; Moreira PI; Proença T; Deshpande A; Busciglio J; Pereira C; Oliveira CR
    Free Radic Biol Med; 2008 Jun; 44(12):2051-7. PubMed ID: 18423383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.